Abbott

Abbott’s Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit™ BTK System) is a first-of-its-kind dissolving stent that sets a new standard of care for people with PAD BTK. The Esprit BTK System is designed to keep arteries open and deliver a medication to support vessel healing before completely dissolving. Via a small incision in the leg, the device is implanted during a catheter-based, minimally invasive procedure. Esprit BTK System is engineered with a poly-L-lactic acid (PLLA) resorbable scaffold to help keep the treated artery open and stable after a procedure, which is crucial to prevent the vessel from narrowing or tearing. Abbott uses a proprietary processing technique to create the right balance of strength and flexibility for the scaffold pattern. Once the Esprit BTK System is implanted, stabilized, and the drug has been delivered, the material will slowly dissolve over time, like dissolvable sutures, leaving an open vessel. Abbott’s Esprit BTK System uses technology to meet the critical needs of those living with PAD BTK, marking a major advancement for people with this painful disease.